A lot of women with PCOS were told for years that the condition was about cysts on their ovaries. As of this week, the name has officially changed. Polycystic ovary syndrome is now polyendocrine metabolic ovarian syndrome, or PMOS. The new name was published in The Lancet and announced May 12, 2026 at the European Congress of Endocrinology in Prague.

The diagnostic criteria have not changed. The condition is the same. The name finally reflects what 30 to 40 years of research has shown: this is a hormone and metabolic condition, not a cyst problem.

Why the old name was misleading

PCOS was named 91 years ago, when researchers thought they were seeing cysts in the ovaries. They were not. What shows up on ultrasound are follicles, which are small fluid-filled sacs that support egg development. In PMOS, those follicles often don’t mature properly and release irregular amounts of hormones.

A true ovarian cyst is a different condition entirely. The “polycystic” label confused patients, family doctors, and even some specialists for almost a century.

The other problem with the old name: it pointed at the ovaries as if that was the whole story. For a lot of women, the ovarian symptoms are not even the most disruptive part. Insulin resistance, weight gain around the midsection, acne, scalp hair thinning, fatigue, and mood changes can show up long before anyone notices an irregular cycle.

What the new name actually means

The new name has two parts that matter.

Polyendocrine means multiple hormone (endocrine) glands are involved. It is not just an ovary issue. The adrenal glands, the pancreas, and the way the body handles insulin are all part of the picture.

Metabolic acknowledges what most women with this condition already feel: blood sugar regulation, body composition, and cardiovascular risk are part of the condition, not separate problems.

For patients, this matters because care can finally be framed around the full clinical picture instead of being filtered through a fertility lens.

What hasn’t changed

The diagnostic criteria in Canada are the same. PMOS is diagnosed when two of the following three are present:

Irregular or absent menstrual cycles, and/or anovulatory cycles or lack of ovulation, meaning ovulation did not occur.
Clinical or lab signs of high androgens (acne, excess facial or body hair, scalp hair thinning, or elevated testosterone or DHEAS on bloodwork).
An ultrasound showing increased follicle count, or elevated anti-müllerian hormone (AMH) on a blood test.

The symptoms have not changed: irregular periods, acne, hair changes, weight gain, blood sugar issues, mood changes, and challenges with fertility. The associated risks have not changed either: higher rates of type 2 diabetes, high blood pressure, sleep apnea, and endometrial cancer if cycles go unmanaged for years.

If you were already diagnosed with PCOS, you have PMOS. The diagnosis is the same; the label is more accurate.

Why this matters for diagnosis and care

One of the most common patterns in women with this condition is being dismissed in their late teens or early 20s and told to come back when they want to get pregnant. The fertility framing has been a real problem for women who were not trying to conceive and who needed care for the other symptoms.

The new name makes it harder to wave off the metabolic and hormonal symptoms. It also creates space for earlier diagnosis. A 16-year-old with irregular cycles, insulin resistance, and acne deserves a workup, not a 10-year wait.

How an ND approaches PMOS

The foundations matter more than any single protocol. That means looking at:

Diet, with a focus on protein, fibre, healthy fats, and stable blood sugar.
Sleep and screen exposure.
Strength training and daily movement, framed as body composition rather than weight loss.
Stress load and recovery.
Bloodwork to confirm what is actually happening: a thyroid panel, fasting insulin or A1C, total and free testosterone, SHBG, DHEAS, LH, FSH, prolactin, vitamin D, B12, iron, and a lipid panel.

From there, targeted support can be layered in. Evidence-backed options for PMOS include myo-inositol, vitamin D where deficient, omega-3, magnesium, and N-acetylcysteine in specific cases.

Prescription support from your family doctor or gynecologist (metformin, GLP-1s, oral contraceptives, spironolactone) is appropriate when warranted. Naturopathic care works alongside that, not against it.

For a deeper walk-through of how this looks in practice, see the guide on naturopathic care for PMOS in Ontario. The clinical approach has not changed with the rename; only the language has caught up.

One step at a time

If you suspect you have PMOS, or you were diagnosed with PCOS years ago and never got a clear plan, the next step is bloodwork. Most of the relevant tests are covered by OHIP when ordered through your family doctor or NP, so that is usually the most affordable starting point.

You can also order bloodwork through your naturopathic doctor. Lab work ordered by an ND is not covered by OHIP, but many extended health benefit plans cover part or all of the cost. It is worth checking your insurance package before you decide which route to take.

You can book a consultation to review your labs and build a plan around the foundations first.

References

Teede HJ et al. “Renaming polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome.” The Lancet, 2026.
La Grassa J. “PCOS, which affects tens of millions of women, is now known as PMOS. Here’s why the renaming is important.” CBC News, May 12, 2026.